Price (delayed)
$3.61
Market cap
$269.28M
P/E Ratio
24.07
Dividend/share
N/A
EPS
$0.15
Enterprise value
$1.82M
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides
There are no recent dividends present for OSUR.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.